Specific reaction of Met 35 in amyloid beta peptide with hypochlorous acid

References

• Selkoe DJ. Alzheimer disease: genes, proteins, and therapy. Physiol Rev 2001;81:741–766.
   PubMed Web of Science ®Google Scholar
• Zhu X, Su B, Wang X, Smith MA, Perry G. Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 2007;64:2202–2210.
   PubMed Web of Science ®Google Scholar
• Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001;60:759–767.
   PubMed Web of Science ®Google Scholar
• Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA. Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 2006;65:631–641.
   PubMed Web of Science ®Google Scholar
• Lovell MA, Ehmann WD, Mattson MP, Markesbery WR. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol Aging 1997;18:457–461.
   PubMed Web of Science ®Google Scholar
• Green PS, Mendez AJ, Jacod JS, Crowley JR, Growdon W, Hyman BT, Heineke JW. Neuronal expression of myeloperoxidase is increased in Alzheimer's disease. J Neurochem 2004;90:724–733.
   PubMed Web of Science ®Google Scholar
• Lovell MA, Robertson JD, Teesdale WJ, Cambell JL, Markesbery WR. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 1998;158:47–52.
   PubMed Web of Science ®Google Scholar
• Samuni A, Aronovitch J, Godinger D, Chevion M, Czapski G. On the cytotoxicity of vitamin C and metal ions. A site-specific Fenton mechanism. Eur J Biochem 1983;137:119–124.
   PubMedGoogle Scholar
• Smith MA, Harris PLR, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 1997;94:9866–9868.
   PubMed Web of Science ®Google Scholar
• Perry G, Taddeo MA, Petersen RB, Castellani RJ, Harris PLR, Siedlak SL, Cash AD, Liu Q, Nunomura A, Atwood CS, Smith MA. Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease. Biometals 2003;16:77–81.
   PubMed Web of Science ®Google Scholar
• Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994;77:817–827.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 2004;6:1054–1061.
   PubMed Web of Science ®Google Scholar
• Crouch PJ, Blake R, Duce JA, Ciccotosto GD, Li QX, Barnham KJ, Curtain CC, Cherny RA, Cappai R, Dyrks T, Masters CL, Trounce IA. Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β1-42. J Neurosci 2005;25:672–679.
   PubMed Web of Science ®Google Scholar
• Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP, Tanzi RE, Bush AI. Characterization of copper interactions with Alzheimer Aβ peptides: identification of an attomolar-affinity copper binding site on amyloid β1-42. J Neurochem 2000;75:1219–1233.
   PubMed Web of Science ®Google Scholar
• Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, Cuajungco MP, Gray DN, Lim J, Moir RD, Tanzi RE, Bush AI. The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999;38:7609–7616.
   PubMed Web of Science ®Google Scholar
• Bishop GM, Robinson SR. The amyloid paradox: amyloid- β-metal complexes can be neurotoxic and neuroprotective. Brain Pathol 2004;14:448–452.
   PubMed Web of Science ®Google Scholar
• Schöneich C, Williams TD. Cu(II)-catalyzed oxidation of β-amyloid peptide targets His13 and His14 over His6: Detection of 2-Oxo-histidine by HPLC-MS/MS. Chem Res Toxicol 2002;15:717–722.
   PubMed Web of Science ®Google Scholar
• Kowalik-Jankowska T, Ruta M, Wisniewska K, Lankiewicz L, Dyba M. Products of Cu(II)-catalyzed oxidation in the presence of hydrogen peroxide of the 1-10, 1-16 fragments of human and mouse β-amyloid peptide. J Inorg Biochem 2004;98:940–950.
   PubMed Web of Science ®Google Scholar
• Cuajungco MP, Goldstein LE, Nunomura A, Smith MA, Lim JT, Atwood CS, Huang X, Farrag YW, Perry G, Bush AI. Evidence that the β-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc. J Biol Chem 2000;275:19439–19442.
   PubMed Web of Science ®Google Scholar
• Kontush A, Berndt C, Weber W, Akopyan V, Arlt S, Schippling S, Beisiegel U. Amyloid-β is an antioxidant for lipoprpteins in cerebrospinal fluid and plasma. Free Radic Biol Med 2001; 30:119–128.
   PubMed Web of Science ®Google Scholar
• Kontush A. Amyloid-β: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease. Free Radic Biol Med 2001;31:1120–1131.
   PubMed Web of Science ®Google Scholar
• Atwood CS, Obrenovich ME, Liu T, Chan H, Perry G, Smith MA, Martins RN. Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β. Brain Res Brain Res Rev 2003;43:1–16.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Shishido N, Nakayama K, Nunomura A, Smith MA, Perry G, Nakamura M. Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-β peptide. Free Radic Biol Med 2007;43:1552–1559.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Shishido N, Nunomura A, Smith MA, Perry G, Hayashi Y, Nakayama K, Hayashi T. Three histidine residues of amyloid-β peptide control the redox activity of copper and iron. Biochemistry 2007;46:12737–12743.
   PubMed Web of Science ®Google Scholar
• Lefkowitz DL, Lefkowitz SS. Microglia and myeloperoxidase: a deadly partnership in neurodegenerative disease. Free Radic Biol Med 2008;45:726–731.
   PubMed Web of Science ®Google Scholar
• Bianca VD, Dusi S, Bianchini E, Dal Pra I, Rossi F. β-Amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J Biol Chem 1999;274:15493–15499.
   PubMed Web of Science ®Google Scholar
• Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O’Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383–421.
   PubMed Web of Science ®Google Scholar
• Dong J, Atwood CS, Anderson VE, Siedlak SL, Smith MA, Perry G, Carey PR. Metal binding and oxidation of amyloid-β within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 2003;42:2768–2773.
   PubMed Web of Science ®Google Scholar
• Naiki H, Higuchi K, Hosokawa M, Takeda T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem 1989;177:244–249.
   PubMed Web of Science ®Google Scholar
• LeVine H 3rd. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 1999;309:274–284.
   PubMed Web of Science ®Google Scholar
• Kettle AJ, Winterbourn CC. Superoxide modulates the activity of myeloperoxidase and optimizes the production of hypochlorous acid. Biochem J 1988;252:529–536.
   PubMed Web of Science ®Google Scholar
• Pattison DI, Davies MJ. Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds. Chem Res Toxicol 2001;14:1453–1464.
   PubMed Web of Science ®Google Scholar
• Pattison DI, Hawkins CL, Davies MJ. Hypochlorous acid-mediated oxidation of lipid components and antioxidants present in low-density lipoproteins: absolute rate constants, product analysis, and computational modeling. Chem Res Toxicol 2003;16:439–449.
   PubMed Web of Science ®Google Scholar
• Sumitomo K, Shishido N, Aizawa H, Hasebe N, Kikuchi K, Nakamura M. Effects of MCI-186 upon neutrophil-derived active oxygens. Redox Rep 2007;12:189–194.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Yoshino K, Kinumi T, Takayama M. Why can reflectron mode in matrix-assisted LASER desorption/ionization time-of-flight mass spectrometry perform MS/MS-like analysis? J Mass Spectrom Soc Jpn 2008;56:263–268.
   Google Scholar
• Nakamura M, Nakamura S. One- and two-electron oxidations of luminol by peroxidase systems. Free Radic Biol Med 1998;24:537–544.
   PubMed Web of Science ®Google Scholar
• Stadtman ER, Van Remmen H, Richardson A, Wehr NB, Levine RL. Methionine oxidation and aging. Biochim Biophys Acta 2003;1703:135–140.
   Web of Science ®Google Scholar
• Palmblad M, Westlind-Danielsson A, Bergquist J. Oxidation of methionine 35 attenuates formation of amyloid β-peptide 1-40 oligomers. J Biol Chem 2002;277:19506–19510.
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Kanski J. Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid β-peptide 1-42. Peptides 2002;23:1299–1309.
   PubMed Web of Science ®Google Scholar
• Misiti F, Martorana GE, Nocca G, Di Stasio E, Giardina B, Clementi ME. Methionine 35 oxidation reduces toxic and pro-apoptotic effects of the amyloid β-protein fragment (31-35) on isolated brain mitochondria. Neuroscience 2004;126: 297–303.
   PubMed Web of Science ®Google Scholar
• Clementi ME, Marini S, Coletta M, Orsini F, Giardina B, Misiti F. Aβ(31-35) and Aβ(25-35) fragments of amyloid beta-protein induce cellular death through apoptotic signals: Role of the redox state of methionine-35. FEBS Lett 2005; 579:2913–2918.
   PubMed Web of Science ®Google Scholar
• Zou K, Gong JS, Yanagisawa K, Michikawa M. A novel function of monomeric amyloid β-protein serving as an antioxidant molecule against metal-induced oxidative damage. J Neurosci 2002;22:4833–4841.
   PubMed Web of Science ®Google Scholar
• Prütz WA. Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates. Arch Biochem Biophys 1996;332:110–20.
   PubMed Web of Science ®Google Scholar
• Prütz WA. Interactions of hypochlorous acid with pyrimidine nucleotides, and secondary reactions of chlorinated pyrimidines with GSH, NADH, and other substrates. Arch Biochem Biophys 1998;349:183–191.
   PubMed Web of Science ®Google Scholar
• Klebanoff SJ. Myeloperoxidase-mediated cytotoxic systems. In: Subarra AJ, Strauss RR, editors. The reticuloendothelial system. A comprehensive treatise. New York and London: Plenum Press; 2000. p 279–308.
   Google Scholar
• Marquez LA, Dunford HB. Kinetics of oxidation of tyrosine and dityrosine by myeloperoxidase compounds I and II. Implications for lipoprotein peroxidation studies. J Biol Chem 1995;270:30434–30440.
   PubMed Web of Science ®Google Scholar
• Syme CD, Nadal RC, Rigby SE, Viles JH. Copper binding to the Amyloid-β(Aβ) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Aβ-(1-28): insights from a range of complementary spectroscopic techniques. J Biol Chem 2004;279:18169–18177.
   PubMed Web of Science ®Google Scholar
• Atwood CS, Huang X, Moir RD, Smith MA, Tanzi RE, Roher AE, Bush AI, Perry G. Neuroinflammatory responses in the Alzheimer's disease brain promote the oxidative post-translational modification of amyloid deposits. In: Iqbal K, Sisodia SS, Winblad B, editors. Alzheimer's disease: Advances in etiology, pathogenesis and therapeutics. Chichester, UK: John Wiley & Sons, Ltd. p 341–361.
   Google Scholar
• DeWitt DA, Perry G, Cohen M, Doller C, Silver J. Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp Neurol 1998;149:329–340.
   PubMed Web of Science ®Google Scholar